GL1X · GenesisL1 explorer

Research workbench

Human estrogen receptor beta ligand-binding domain in complex with compound 45

Analyse Human estrogen receptor beta ligand-binding domain in complex with compound 45 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2GIU
Type
protein
Length
225 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Estrogen receptor beta
UniProt
Q92731
Ligands
FBR
Pockets
2 · best druggability 0.83

Structure

x-ray diffraction · 1 distinct chain · 71% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AEstrogen receptor betaprotein22571% helix, 4% strandQ92731

Ligands and binding sites

  • FBR · (9aS)-4-bromo-9a-butyl-7-hydroxy-1,2,9,9a-tetrahydro-3H-fluoren-3-one · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11940.830.9624FBR
2990.550.8420empty

Compared structures

  • 2GIU · Human estrogen receptor beta ligand-binding domain in complex with compound 45 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q92731 · AlphaFold monomer V2.0 prediction for estrogen receptor beta (Q92731) · a predicted model of the same protein · chain A against A, TM-score 0.92

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.